期刊文献+

不同类型多发性骨髓瘤患者的凝血异常分析及其与血清球蛋白的相关性 被引量:10

Coagulation disorder analysis in patients with different types of multiple myeloma and its correlation with serum globulin
下载PDF
导出
摘要 目的探讨不同类型初诊多发性骨髓瘤(MM)患者的凝血指标变化及其与血清球蛋白的相关性。方法检测80例MM患者(其中轻链型24例、Ig G型36例、Ig A型20例)与38例健康体检者的凝血指标及血清球蛋白水平,比较各组间凝血指标变化,并分析其与血清球蛋白相关性。结果 Ig A组和Ig G组MM患者的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)高于轻链组和对照组(P<0.05);各组间纤维蛋白原(FIB)、凝血酶时间(TT)水平差异无统计学意义(P>0.05);轻链组D-二聚体高于Ig A和Ig G组(P<0.05)。80例MM患者中,Ig A组和Ig G组MM患者的血清球蛋白水平高于轻链组(P<0.05);血清球蛋白水平与PT、APTT呈正相关(r=0.713和0.613),与D-二聚体无相关性。结论 MM患者存在凝血异常,Ig A、Ig G型MM更易于影响凝血系统,轻链型MM更倾向形成血栓,且MM的PT、APTT异常与血清球蛋白水平相关。 Objective To investigate coagulation disorder and its correlation with serum globulin in different types of patients with primary myeloma(MM).Methods Totally 80 patients with MM(24 cases of light chain type,36 cases of IgG type,20 cases of IgA type)and 38 cases of healthy subjects were involved in this study.The blood coagulation indexes and serum globulin levels were measured.Correlation between the indexes of coagulation and serum globulin was determined.Results PT and APTT were upregulated significantly in group IgA and group IgG compared with light chain group and control group(P<0.05).No significant difference in FIB and TT were identified among all groups(P>0.05).Patients in Light chain group experienced increased levels of D-dimer compared with IgA and IgG group(P<0.05).upregulated levels of serum globulin were founded in IgA group and IgG group when compared with light chain group(P<0.05).Serum levels of globulin were positively correlated with PT and APTT(r=0.713 and 0.613,respectively)while obvious relationship was suggested between serum globin and D-dimer.Conclusion MM patients with IgA type and IgG type MM are more likely to exert the coagulation dysfunction while patients with light chain type prompt to thrombosis;serum globulin is positively associated with PT and APTT levels.
作者 张荣娟 韩凝 王丽红 闫丽娜 张志华 Rong-juan Zhang;Ning Han;Li-hong Wang;Li-na Yan;Zhi-hua Zhang(Department of Hematology,Affiliated Hospital of Chengde Medical University,Chengde,Hebei 067000,China)
出处 《中国现代医学杂志》 CAS 2018年第21期58-62,共5页 China Journal of Modern Medicine
基金 河北省自然科学基金(No:H2013406112)
关键词 多发性骨髓瘤 凝血功能 抗凝功能 纤溶功能 血清球蛋白 multiple myeloma coagulation function anticoagulant function fibrinolysis function serum globulin
  • 相关文献

参考文献5

二级参考文献19

  • 1郝丽,郑成中.支原体肺炎患儿D-二聚体、免疫功能变化及其意义[J].中国生化药物杂志,2014,34(3):156-159. 被引量:34
  • 2季杰,刘慧林,程金莲,王麟鹏.三通法针刺对急性缺血性脑血管病患者血清TNF-α及IL-1β的影响[J].中国中西医结合杂志,2006,26(6):500-503. 被引量:25
  • 3Leebeek FW,Kruip MJ,Sonneveld P,et al.Risk and management of thrombosis in multiple myeloma.Thromb Res,2012;129 Suppl 1:S88-92.
  • 4Zangari M,Barlogie B,Thertulien R,et al.Thalidomide and deep vein thrombosis in multiple myeloma:risk factors and effect on survival.Clin Lymphoma,2003;4(1):32-35.
  • 5Corso A,Lorenzi A,Terulla V,et al.Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.Ann Hematol,2004;83(9):588-591.
  • 6Zappasodi P,Mangiacavalli S,Terulla V,et al.Thrombomodulin levels are not modified during thalidomide treatment.Eur J Haematol,2006;77(5):453-454.
  • 7Petropoulou AD,Gerotziafas GT,Samama MM,et al.In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide.Thromb Res,2008;121(4):493-497.
  • 8Streetly M,Hunt BJ,Parmar K,et al.Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid(CC-4047)and their relationship with venous thrombosis.Eur J Haematol,2005;74(4):293-296.
  • 9姚弘,林永财,张忠英.恶性肿瘤患者血清Kappa与Lambda轻链检测及临床意义[J].国际检验医学杂志,2009,30(6):562-563. 被引量:2
  • 10廖爱军,胡荣,李迎春,姚鲲,王慧涵,张嵘,杨威,刘卓刚.FTY720诱导多发性骨髓瘤细胞株U266自噬与凋亡的研究[J].中华血液学杂志,2011,32(10):664-667. 被引量:8

共引文献53

同被引文献66

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部